Sebela Pharmaceuticals clinical trials
The registry lists 56 studies whose lead sponsor is Sebela Pharmaceuticals or one of 3 companies grouped under it. 1 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 13, 2026.
Our grouping of 3 registry names, not the registry’s. See them and correct one ↓
- 56studies on the registry
- 1open to participants now
- 2phase 3 studies under way
Get an email when these change. Save the Sebela Pharmaceuticals studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
What it is testing
The drugs Sebela Pharmaceuticals’ studies test, most studies first; none is open now — 12 drugs with a page of their own. Each count opens the studies in search.
Studies, none open
- polyethylene glycol 33502 in phase 30 open · 10
- BLI8005 in phase 30 open · 8
- BLI8011 in phase 30 open · 5
- BLI47002 in phase 30 open · 4
- lactitol3 in phase 30 open · 4
- lactitol monohydrate3 in phase 30 open · 4
- Bisacodyl2 in phase 30 open · 3
- Potassium Chloride2 in phase 30 open · 3
- Sodium Bicarbonate2 in phase 30 open · 3
- Sodium Chloride2 in phase 30 open · 3
Show 2 moreShow fewer
- tegoprazan3 in phase 30 open · 3
- Nizatidine1 in phase 30 open · 1
All 56 at a glance
Where each study is in its life, its phase and its countries. Each count opens them in search.
Over the years
- 07
- 08
- 09
- 10
- 11
- 12
- 13
- 14
- 15
- 716
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 126
By the year each study started; 11 started before 2007. 2026 so far in the lighter column.
Registry sponsor names on this page
Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.
Tell us about a missing company
Each name exactly as ClinicalTrials.gov lists it, and how it relates to Sebela Pharmaceuticals.
- Braintree Laboratories49 studies →Acquired — became part of Sebela Pharmaceuticals, May 1, 2018 · source ↗
Something wrong?
- Sebela Women's Health Inc.6 studies →Subsidiary
Something wrong?
- Sebela Pharmaceuticals Development LLC1 study →Subsidiary
Something wrong?
Focus areas
Conditions Sebela Pharmaceuticals leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.
Studies
Recruiting first, then most recently updated. Showing 50 of 56. Browse all 56 →
- Evaluation of the Efficacy, Safety, and Tolerability of LevoCeptNot yet recruitingNCT04457076Phase 3
Sponsor listed in the registry: Sebela Women's Health Inc.
- A Study to Evaluate the Efficacy and Safety of BLI5100 in Patients With Non-Erosive Reflux DiseaseCompletedNCT05587322Phase 3
Sponsor listed in the registry: Braintree Laboratories · First submitted after Braintree Laboratories became part of Sebela Pharmaceuticals
- A Study to Evaluate the Efficacy and Safety of BLI5100 in Patients With Erosive EsophagitisCompletedNCT05587309Phase 3
Sponsor listed in the registry: Braintree Laboratories · First submitted after Braintree Laboratories became part of Sebela Pharmaceuticals
- Evaluation of the Efficacy and Safety of LevoCeptCompletedNCT02882191Phase 2
Sponsor listed in the registry: Sebela Women's Health Inc.
- Evaluation of ContraMed VeraCept Intrauterine Copper Contraceptive for Long Acting Reversible ContraceptionCompletedNCT02446821Phase 2
Sponsor listed in the registry: Sebela Women's Health Inc.
- A Study to Evaluate the Long-Term Safety of BLI5100 in Patients With Gastroesophageal Reflux DiseaseCompletedNCT05890001Phase 3
Sponsor listed in the registry: Braintree Laboratories · First submitted after Braintree Laboratories became part of Sebela Pharmaceuticals
- Evaluation of Efficacy, Safety and Tolerability of VeraCept IUSActive, not recruitingNCT03633799Phase 3
Sponsor listed in the registry: Sebela Women's Health Inc.
- A PK Study Comparing VeraCept vs. ParaGard Intrauterine Devices (IUDs)CompletedNCT03785366Phase 3
Sponsor listed in the registry: Sebela Women's Health Inc.
- A Safety Study of 3 Different Bowel Cleansing PreparationsCompletedNCT01501513Phase 3
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- BLI4700-202: A Pilot Evaluation of BLI4700 Bowel Preparation in Adult SubjectsCompletedNCT03103581Phase 2
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- A Pilot Evaluation of BLI4700 Bowel Preparation in Adult SubjectsCompletedNCT03023085Phase 1/2
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- A Safety and Efficacy Study of BLI-1300 Ointment in Symptomatic Perianal Crohn's DiseaseTerminatedNCT01442363Phase 2
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- A Safety and Efficacy Evaluation of BLI801 Laxative in Adults Experiencing Non-Idiopathic ConstipationCompletedNCT02822508Phase 2/3
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- Study 301: BLI4900 Versus an FDA-approved Comparator in Adult Subjects Prior to ColonoscopyCompletedNCT04446299Phase 3
Sponsor listed in the registry: Braintree Laboratories · First submitted after Braintree Laboratories became part of Sebela Pharmaceuticals
- Study 302: BLI4900 Versus an FDA-approved Comparator in Adult Subjects Prior to ColonoscopyCompletedNCT04446312Phase 3
Sponsor listed in the registry: Braintree Laboratories · First submitted after Braintree Laboratories became part of Sebela Pharmaceuticals
- A Pilot Evaluation of BLI4900 Bowel Preparation in Adult SubjectsCompletedNCT03328507Phase 2
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- An Open-Label Preference Evaluation of BLI800CompletedNCT04214301Phase 4
Sponsor listed in the registry: Braintree Laboratories · First submitted after Braintree Laboratories became part of Sebela Pharmaceuticals
- Comparative Study of the VeraCept Low-Dose Intrauterine Copper Contraceptive vs. the TCu380 Copper IUDCompletedNCT02167763Phase 1
Sponsor listed in the registry: Sebela Women's Health Inc.
- A Safety and Efficacy Comparison of BLI4700 Bowel Preparation Versus an FDA-approved Comparator in Adult Subjects Prior to ColonoscopyCompletedNCT03261960Phase 3
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- A Safety and Efficacy Comparison of BLI4700 Bowel Prep Versus an FDA-approved Comparator in Adults Prior to ColonoscopyCompletedNCT03404401Phase 3
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- A Safety and Efficacy Study of a Bowel Cleansing Preparation (BLI800) in Pediatric Subjects Undergoing ColonoscopyCompletedNCT02819323Phase 3
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- Efficacy, Safety and Tolerability of a Bowel Cleansing Preparation (BLI800) in Pediatric Subjects Undergoing ColonoscopyCompletedNCT02189850Phase 2
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- A Safety and Efficacy Evaluation of BLI400 Laxative in Constipated AdultsCompletedNCT02481947Phase 3
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- BLI400-302: A Safety and Efficacy Evaluation of BLI400 Laxative in Constipated AdultsCompletedNCT02819297Phase 3
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- An Open Label Study of Chronic Use of BLI400 Laxative in Constipated AdultsCompletedNCT02819310Phase 3
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- A Safety and Efficacy Evaluation of BLI400 Laxative in Constipated Adolescent SubjectsCompletedNCT02665728Phase 2
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- A Pilot Study of BLI801 Laxative in Adults Experiencing Non-Idiopathic ConstipationCompletedNCT02820714Phase 2
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- Safety and Efficacy Study of an Edible Colonoscopy PreparationCompletedNCT03332485Phase 2
Sponsor listed in the registry: Sebela Pharmaceuticals Development LLC
- A Safety and Efficacy Evaluation of Topical Treatments for Moderate-Severe Facial Acne VulgarisCompletedNCT02604680Phase 2
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- A Pilot Evaluation of an Experimental BLI4600 Formulation for Bowel Preparation in Adult Patients Undergoing ColonoscopyCompletedNCT02376465Phase 2
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- BLI1100-202: BLI1100 for the Treatment of Moderate to Severe Acne VulgarisCompletedNCT01815450Phase 2
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- BLI800-480: A Safety and Efficacy Evaluation of 2 Different Bowel Cleansing Preparations in Adult SubjectsCompletedNCT01786629Phase 4
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- A Safety and Efficacy Evaluation of BLI801 Laxative in Constipated AdultsCompletedNCT01687985Phase 2
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- BLI850-302: BLI850 vs an Approved Active Control Bowel Preparation in Adult Subjects Undergoing ColonoscopyCompletedNCT00756548Phase 3
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- BLI850 vs an Active Control Bowel Preparation in Adult Subjects Undergoing ColonoscopyCompletedNCT00756977Phase 3
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- Comparison of PolyethyleneGlycol and Placebo for Relief of Constipation From Constipating MedicationsCompletedNCT00153127Phase 4
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- PolyethyleneGlycol3350 Laxative vs Placebo in Constipated ChildrenCompletedNCT00153114Phase 4
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- Polyethyleneglycol3350 vs Tegaserod in Treatment of Patients With Chronic ConstipationCompletedNCT00153140Phase 4
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- An Open Label Study of Chronic Polyethyleneglycol3350 Use in Constipated PatientsCompletedNCT00164125Phase 4
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- A Pilot Study of a New MiraLax® Dose Formulation For Use in Constipated ChildrenCompletedNCT00319670Phase 4
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- HalfLytely Bowel Prep System for ColonoscopyCompletedNCT00164164Phase 3
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- Extended Use of Polyethyleneglycol3350 Laxative in Constipated PatientsCompletedNCT00153153Phase 4
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- A Comparison of the Efficacy and Safety of HalfLytely Vs Visicol Prior To Colonoscopy.CompletedNCT00164151Phase 3
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- Evaluation Of The Efficacy Of HalfLYTELY For Bowel Cleansing Before Virtual Colonoscopy and Conventional Colonoscopy.CompletedNCT00164177Phase 4
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- BLI1100 for the Treatment of Moderate to Severe Acne VulgarisCompletedNCT01241331Phase 2
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- BLI801 Laxative in Constipated AdultsCompletedNCT01301781Phase 2
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- An Open Label Study to Assess the Effect of BLI800 on Safety and Clinical Chemistry ParametersCompletedNCT00583713Phase 1/2
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- BLI800-303: An Efficacy Evaluation of 2 Different Bowel Cleansing Preparations in Adult SubjectsCompletedNCT00856843Phase 3
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- F38-27: An Evaluation of 2 Different Bowel Cleansing Preparations in Adult SubjectsCompletedNCT00857272Phase 4
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals
- Safety and Efficacy Study of Axid Use in Infants Suffering From Gastroesophageal Reflux Disease (GERD)CompletedNCT00373334Phase 3
Sponsor listed in the registry: Braintree Laboratories · First submitted before Braintree Laboratories became part of Sebela Pharmaceuticals